In the case of nonclinical populations, experiments are defined by psychobiotic supplementation in rodents that have unimpaired psychophysiological processes and microbiomes. For example, one study examined the effects of probiotics in healthy adult male BALB/c mice (n = 36), which Glossary Colonisation: bacterial colonisation is believed to begin during parturition. Infant gut bacteria carry a maternal signature, though the mode of delivery substantially influences the composition of the early microbiota. The human infant's microbiome comes to resemble the adult microbiome in complexity and richness in the first 1 to 3 years. Commensal gut bacteria: communities of indigenous bacteria residing in the intestinal tracts that share symbiotic relationships with the host. Bacteria comprise the vast majority of the microbiome, including at least 1000 distinct species and 7000 strains. Anaerobic bacteria are the chief residents of this community, which is composed mainly of Firmicutes and Bacteroidetes (up to 75%) along with smaller communities of Actinobacteria, Fusobacteria, Proteobacteria, and Verrucomicrobia. Alongside bacteria reside smaller numbers of archaea, bacteria, fungi, protozoa, and viruses. Cytokine: proteins that facilitate cell-cell signalling. They serve an essential role in the organism's immune activity, and balance inflammation in response to pathogenic or infectious entities. Proinflammatory cytokines enhance inflammation, while anti-inflammatory cytokines suppress inflammation. Healthy immune function requires balanced pro-and anti-inflammatory cytokines. Depression and anxiety have both been associated with excessive pro-inflammatory cytokines. Enteric nervous system: a subdivision of the nervous system embedded throughout the entire gastrointestinal tract, regulating all gastrointestinal function (e.g., gut motility, mucus secretion, blood flow, and immunological and endocrine activity). Glucocorticoid stress response: a hormonal end-product of activity in the hypothalamic-pituitary-adrenal (HPA) axis. Glucocorticoids such as cortisol and corticosterone are wellvalidated biomarkers of stress. In particular, circulating glucocorticoid concentrations increase in response to psychological and physical stress. Their secretion alters glucose metabolism and inhibits immunological activity. They also increase threat sensitivity and negative mood, and impair memory and other cognitive functions. In humans, cortisol is the glucocorticoid that performs these functions. In rats and mice, corticosterone exerts these effects. Overall, though cortisol and corticosterone have somewhat different molecular structures, they are functionally similar in their physiological and psychological effects. While glucocorticoids prepare the organism to deal with stressful or uncertain situations, dysregulated HPA-activity and glucocorticoid levels are associated with anxiety and depression. Gut-brain axis: a network comprising the gastrointestinal tract, the enteric nervous system, and the brain. Bidirectional communications between these entities regulate several important functions, including immunity, digestion, metabolism, satiety, and stress reactions. Messenger ribonucleic acid: mRNA carries genetic information for the coding of particular proteins from the deoxyribonucleic acid (DNA) within the cell's nuclear envelope into the cytoplasm, where protein synthesis occurs. Inflammation: an adaptive response to noxious stimuli or experiences, most notably infection or injury. The response involves coordinated activity across a range of biological actors, including cytokines. These processes are targeted at protecting tissue from further damage and repairing or clearing affected tissue. Rodent behavioural tests: in animal models, psychological states such as anxiety and depression must be inferred from behavioural profiles. Various tests allow for the systematic observation of certain behaviours that correspond closely to the psychological state of interest. These tests have also been shown to accurately capture anxiolytic and antidepressant effects. In mazelearning tasks, rodents are exposed to novel environments. Over time, they develop spatial representations for the maze through attempts to navigate it. Anxiety impairs this learning process. The Morris water maze, in which rodents swimming in pools of water must find a submerged platform which allows them to stop swimming, tests similar processes by exploiting the evolutionary fear of drowning. In the elevated plus maze, an evolutionary tendency to prefer closed to open spaces is exploited on a maze with 
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were innately stress-sensitive and anxious but were otherwise healthy [21] . Compared to mice administered
and anxious behaviours (in the forced swim and elevated plus maze tasks, respectively). These changes were accompanied by a blunted corticosterone response to stress, suggesting that the probiotic downregulated HPA-axis activity. In the brain, probiotics differentially altered expression of inhibitory GABA receptors in a region-dependent manner. For instance, in comparison to controls, the probiotic reduced expression of GABA B1b mRNA in the hippocampus and amygdala but increased its expression in prelimbic and cingulate regions[ In another study, healthy adult male BALB/c mice fed Mycobacterium vaccae (n = 7-10/group across five experiments) displayed reduced anxiety in a maze-learning task [22] . Furthermore, performance on the maze task was substantially improved in the probiotic-fed mice, which completed the maze faster and with fewer errors, benefits that persisted at 1 week, but not 3 weeks, post-treatment. These results provide preliminary but important evidence of the[ 1 6 7 _ T D $ D I F F ] potential longevity of effects, an area that has received little consideration in psychobiotic research. 
One programme of research [23] investigated the effect of Bifidobacteria infantis on male Sprague-Dawley rats (n = 20) in the forced swim test, stress responses, inflammation, and monoaminergic activity. While there were no behavioural changes in swim test performance, there were significant increases of tryptophan, the serotonin precursor, in the plasma. There were also decreased concentrations of 5-[ 1 6 8 _ T D $ D I F F ] hydroxyindoleacetic acid, the serotonin metabolite, in the brain. This was taken as evidence of reduced serotonergic turnover. Compared to vehiclefed rats, blood from probiotic-fed rats exhibited reduced concentrations of the pro-inflammatory cytokines tumour necrosis factor-/, interleukin-6, and interferon-g. These reductions jointly characterise a dampened The implications of concurrent elevations in both glutamate and GABA for regional excitationinhibition balance are currently unknown, but are suggestive of an overall metabolic increase. Furthermore, because GABA and glutamate have opposing effects on neural excitability, it is possible that the total psychobiotic effect may be occurring within a zero-sum framework. The researchers also conducted periodic MRS, finding differential rates of emergence for the effects. For example, NAA increased after 2 weeks of probiotics, an elevation that was sustained for the remainder of the supplementation, and which returned to baseline 4 weeks thereafter. Glutamate and glutamine levels also increased after 2 weeks, and then remained elevated for a further 6 weeks, including 4 weeks after the intervention. Finally, GABA concentrations were only elevated in the fourth week of the intervention, but not before or after. These results represent a crucial step towards [ 1 7 6 _ T D $ D I F F ] determining emergence and longevity of effects. While the general consensus is that ingestion of probiotics results in transient, rather than permanent, colonisation of the gut [26], these findings suggest both that psychobiotics may have some long-term effects, and that the effects have differential longevity.
Prebiotics A much smaller number of studies has examined the psychophysiological effects of prebiotics. These include investigations of galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), which are a source of nutrition for Bifidobacteria and Lactobacilli, and stimulate their activity and propagation in the gut. The first report of[ 1 7 7 _ T D $ D I F F ] the psychobiotic properties of prebiotics examined adult male Sprague-Dawley rats (n = 24) that were administered the Bimuno formulation of GOS (B-GOS), FOS, or water, over 5 weeks [27] . Relative to controls, prebiotic ingestion increased hippocampal BDNF expression and BDNF mRNA expression in the dentate gyrus. Prebiotic feeding also increased N-methyl-D-aspartate receptor (NMDAR) subunits expressed in the hippocampus. These receptors play an essential role in maintaining synaptic plasticity and optimal memory function [28] . Both B-GOS and FOS elevated NR1 subunit expression in the hippocampus, with B-GOS additionally increasing NR2A subunits in this region, and NR1 and D-serine in the frontal cortex. The more widespread B-GOS effect, relative to FOS, may reflect the former's greater Bifidogenic capacity. There is also evidence of substantial benefits conferred by the human milk oligosaccharide 2 0 -fucosyllactose [29] . Relative to vehicle, male rodents (both Sprague-Dawley rats and C57BL/6 mice) showed enhanced associative learning and working memory, as well as higher expression of hippocampal and striatal BDNF and increased hippocampal long-term potentiation.
Prebiotic supplementation has also been studied in neonatal rats [30] . Male and female Sprague-Dawley rat pups (n = 48) were fed daily with B-GOS or a control solution from post-natal day 3 to 21. Animals supplemented with B-GOS expressed higher levels of hippocampal BDNF and NMDAR subunit GluN2A 
Human Research
Probiotics
The rodent-human translation has been surprisingly robust, though many more human studies are necessary. In an important early investigation [32], male and female participants (n = 124) consumed either a fermented milk drink containing Lactobacillus casei Shirota or a placebo. At the end of the 3-week intervention, there were no overall changes in self-reported affect. However, when only participants whose baseline mood scores fell in the lowest third of the total range were analysed, probiotic supplementation resulted in significantly more participants self-rating as happy rather than depressed, relative to placebo. These results suggest that the emotional benefits of psychobiotics may be subject to ceiling effects.
researchers also found that the probiotic-fed participants performed lower on two assessments of memory function. This may be attributable to chance, as the authors themselves have suggested, but it may also imply possible detrimental effects of psychobiotics.
Another well-known study provided evidence of improved mood in a generally healthy sample [33] . In a randomised and double-blind design, healthy male and female volunteers (n = 55) consumed either a mixture of probiotics (Lactobacillus helveticus R0052 and Bifidobacterium longum) or a placebo over 30 days, after which participants completed a range of self-report measures on mood and distress. Participants also collected urine over 24 hours before and after the intervention, enabling cortisol estimations. Relative to placebo, probiotic-treated participants showed significant declines in self-reported negative mood and distress. Parallel to these changes was a decrease in urinary free cortisol, which is suggestive of [38] , which is associated with disturbances in the gutbrain axis [39] and in the composition of the microbiome [40] , and is often accompanied by anxiety and depression [41] . Male and female participants (n = 77) consumed either Lactobacillus salivarius UCC4331, Bifidobacterium infantis 35624, or a placebo. At baseline, participants had an aberrant ratio of interleukin-10 to interleukin-12, suggesting a generalised pro-inflammatory state. Only those participants who consumed Bifidobacterium infantis 35624 displayed a normalisation of this ratio post-treatment. These results indicate both that probiotics can induce cytokine changes in humans, and also that these effects may be specific to particular families or strains of probiotic. However, there is no theoretical basis at present to predict that one form of probiotic would be more effective than
What neural and information-processing changes might underpin these probiotic-induced emotional benefits in humans? Evidence from a neuroimaging study points to a modulation of attention and vigilance to negative emotional stimuli [42] . Over 4 weeks, healthy female participants consumed either a placebo or a mixture of probiotics (Bifidobacterium animalis, Streptococcus thermophiles, Lactobacillus bulgaricus, and Lactococcus lactis), or consumed nothing as part of a passive control (total n = 36). Crucially, participants underwent functional magnetic resonance imaging (fMRI) to determine how probiotic ingestion affected neurophysiological activity. During image acquisition, participants were shown emotional faces that are known to capture attention and cause brain activation, fearful faces in particular [[
Relative to placebo, probiotic-treated participants showed decreased activity in a functional network associated with emotional, somatosensory, and interoceptive processing, including the somatosensory cortex, the insula, and the periaqueductal [ 1 9 1 _ T D $ D I F F ] gray. Placebo participants showed increased activity in these regions in response to emotional faces. This can be interpreted as a probioticinduced reduction in network-level neural reactivity to[ 3 9 _ T D $ D I F F ] emotional information.
Prebiotics
Inductive evidence that psychobiotics modulate emotional appraisal is supplied by the first human study to examine the [ 3 5 _ T D $ D I F F ] psychophysiological effects of prebiotics [44] . Healthy male and female participants (n = 45) consumed either B-GOS, FOS, or a placebo. In comparison to the other two groups, participants who consumed B-GOS showed a significantly reduced wakingcortisol response. Exaggerated waking cortisol is a biomarker of emotional disturbances such as depression [45, 46] . Furthermore, participants completed an emotional dot-probe task that measures vigilance, or attention to negative stimuli, which is also a behavioural marker of anxiety and depression [47] . B-GOS attenuated vigilance, suggestive of reduced attention and reactivity to negative emotions. Attenuated vigilance is considered an anxiolytic and antidepressant effect [48] .
Overall, then, psychobiotics may exert their beneficial effects on mood through modulation of neural networks associated with emotional attention[
The addition of behavioural measures of vigilance, cognitive control, and negative mood to research programmes would richly supplement self-reports. Moreover, their addition is logistically straightforward and incurs minimal additional resources. Reduced attention to negative stimuli may constitute a neurocognitive channel through which psychobiotics improve mood. At the systemic level, reductions in cortisol and pro-inflammatory cytokines would support these processes, given their frequent cooccurrence with negative mood. At present, however, the direction of causality between systemic and brain changes is unknown. Furthermore, longevity and time-courses of effects have not been studied in humans and are even less clear than in rodents.
Bacteria-Brain Signalling
The mechanisms through which psychobiotics exert their effects have yet to be clearly defined and remain poorly understood. Though there are some studies that provide mechanistic insights for humans, the majority of research is based on rodent models. A crucial step in developing knowledge of the mechanisms lies in investigating how the microbiome and the brain communicate with one another (see Figure 1 ).
Bacteria-Enteric Nervous System Interactions
regulate electrophysiological thresholds in enteric nervous system neurons. For example, myenteric neurons exposed to Bifidobacterium longum NCC3001-fermented substances showed reduced generation of action potentials when they were electrically stimulated [49] . Similarly, colonic AH neurons (the chief sensory neurons in the colon) treated with Lactobacillus rhamnosus showed increased excitability, an effect that emerged from inhibition of calcium-controlled potassium gates [50] . Other work showed that neurons from the dorsal root ganglion in the colon did not display hyperexcitability in response to noxious stimulation if they had been treated with Lactobacillus rhamnosus [51, 52] . Myenteric neurons are also in close proximity to the gut lumen [7] , which would facilitate their contact with the microbiome. In germfree mice, these neurons show lower levels of excitability compared to their normally-colonised counterparts [53] . One study found evidence of intestinal neural abnormalities in the jejunum and ileum of germ-free mice in comparison to controls [54] , with germ-free mice showing reduced nerve density, fewer nerves per ganglion, and a greater number of myenteric nitrergic neurons. Recent evidence also indicates that the microbiome affects ion transport controlled by cyclic adenosine monophosphate (cAMP) [55] . GLP-1) . Prebiotics may have stronger effects in this regard in comparison to probiotics. SCFAs and gut hormones enter circulation and can migrate into the central nervous system. Gut hormones are also secreted by tissues other than enteroendocrine cells. Neurotransmitters: psychobiotics enhance neurotransmitter production in the gut, including dopamine (DA), serotonin (5-HT), noradrenaline (NA), and g-aminobutyric acid (GABA), which likely modulate neurotransmission in the proximal synapses of the enteric nervous system. Vagal connections: the vagus nerve synapses on enteric neurons and enables gut-brain communication. Stress, barrier function, and cytokines: barrier dysfunction is exacerbated through stress-induced glucocorticoid exposure. This enables migration of bacteria with [ 1 6 _ T D $ D I F F ] pro-inflammatory components, increasing inflammation directly and also triggering a rise in pro-inflammatory cytokines via the immunogenic response. These cytokines impair the integrity of the blood-brain barrier and permit access to potentially pathogenic or inflammatory elements. Pro-inflammatory cytokines (red circles) also reduce the integrity of the gut barrier. Psychobiotic action restores gut barrier function and decreases circulating concentrations of glucocorticoids and pro-inflammatory cytokines. They also increase concentrations of anti-inflammatory cytokines (blue circles), which enhance integrity of the blood-brain barrier, the gut barrier, and reduce overall inflammation. Cytokines clustering at the brain represent cytokine interaction with the blood-brain barrier. Central lymphatic vessels: cytokines may interact more directly with the brain than previously appreciated through the recently discovered central lymphatic vessels. noradrenalin and serotonin by the Escherichia family, and GABA and acetylcholine by the Lactobacilli family [57] [58] [59] . Though there is no direct evidence as of yet, it is likely that these neurotransmitters modulate synaptic activity in the proximal neurons of the enteric nervous system, and is an important avenue for future research.
Vagal Signalling
The vagus nerve plays an essential and wide-ranging role in coordinating parasympathetic activity, including regulation of heart rate and gut motility. It possesses an abundance of sensory fibres, and is able to convey rich information on organ function throughout the body to the brain [60] . Vagal activity is sensitive to nutrition, exercise, and stress [61] [62] [63] .
Stimulating the vagus nerve exerts anti-inflammatory effects [64] , and is used therapeutically for refractory depression, pain, and epilepsy [65] [66] [67] [68] . There is also evidence of both antidepressants and anxiolytics exerting vagal effects [69] [70] [71] for their digestion, which are supplied by the microbiome [74] . The metabolisation of these fibres produces short-chain fatty acids (SCFAs), including acetate, butyrate, lactate, and propionate [75, 76] . SCFAs enter the circulatory system through the large intestine [77] , where the greater proportion are directed into the liver and muscle. Although it is unclear to what extent the small fraction of SCFAs crossing into the central nervous system modulates neurotransmission, there is some evidence for their psychotropic properties at pharmacological concentrations. For instance, systemic sodium butyrate injections (200 mg/kg body weight) in rats produce antidepressant effects, and increase central serotonin neurotransmission and BDNF expression [78] . Here, the action of butyrate as an epigenetic modifier [79] is more likely compared to action as an agonist at a free fatty acid receptor (FFAR), given that there are few FFARs in the brain [80] . However, it should be noted that the SCFAs display pleiotropy (independent effects produced by a single gene), and also stimulate the HPA axis [81] or have direct effects on the mucosal immune system [82] , which may indirectly affect central neurotransmission. A recent rodent investigation [83] has also found that the SCFA acetate plays a causal role in obesity. Acetate generated by the gut bacteria in response to high-fat diets triggers parasympathetic activity and promotes increases in ghrelin, glucosestimulated insulin, and further nutrition intake, creating a positive feedback loop that increases the likelihood of obesity.
SCFAs also influence secretion of satiety peptides, including cholecystokinin (CCK), peptide tyrosine tyrosine (PYY) and glucagon-like peptide-1 (GLP-1), from gut mucosal enteroendocrine cells which express FFARs [84] . For instance, propionic acid mediates the release of GLP-1 and PYY through activation of FFAR2 [85] . Consistent with the concept that SCFAs are produced from the bacterial metabolism of dietary polysaccharides, prebiotic supplementation increases the production of intestinal SCFAs, which modulate enteroendocrine cells and their secretion of PYY and GLP-1 [77, 86] . It is therefore reasonable that the satiety hormones may play a more significant role in the central effects of prebiotics compared to probiotics. [91] . For instance, germ-free mice had 40% greater plasma tryptophan concentrations than normal mice, but the [ 2 1 8 _ T D $ D I F F ] normal mice had 2.8 times greater plasma serotonin levels than the germ-free mice. This suggests that gut bacteria crucially affect the metabolism of tryptophan into serotonin in Enterochromaffin cells (serotonin-secreting cells embedded in the luminal epithelium). Though the specific mechanism through which bacteria might control serotonin production in Enterochromaffin cells was unknown at that time, a recent study has attributed this role to indigenous spore-forming bacteria in the gut [92] . There were similarly dramatic differences in other tryptophan metabolites, especially those containing indole, such as the antioxidant indole-3-propionic acid (IPA) and indoxyl sulphate, which were undetected in the germ-free mice and whose production was therefore interpreted as being fully mediated by gut bacteria.
We speculate that these metabolites are sensitive to psychobiotic action. However, the relationships between the microbiome, bacteria-derived metabolites, and the central nervous system, as well as the role of psychobiotics in modulating this network, remain virtually unexplored.
Bacteria-Immune Interactions
A key function of the immune system is to detect and eliminate [ 2 1 9 _ T D $ D I F F ] pathogens. Every microbe possesses a microbe-associated molecular pattern (MAMP, previously referred to as pathogen-associated molecular patterns) [93] . A range of microscopic elements may act as MAMPs, including microbial nucleic acids, molecular cell wall components (e.g., lipopolysaccharides[ 4 6 _ T D $ D I F F ] ), or bacterial flagella. Gut microbes can communicate with the enteric nervous system and the innate immune system via interactions between the MAMPs and pattern-recognition receptors embedded along the lumen. The family of pattern-recognition receptors includes Toll-like receptors (TLRs), C-type lectins, and inflammasomes. These receptors are able to detect the nature and potential effects of various microbes via the MAMPs and, at a broad level, transmit information about the microbial environment to the host, enabling specific immunological responses.
The MAMPs of beneficial bacteria, by triggering pattern-recognition receptors, may precipitate secretion of anti-inflammatory cytokines such as interleukin-10 [38, 94] . While rigorous mechanistic descriptions of the relationship between MAMPs, pattern-recognition receptors, and reductions in inflammation are lacking, one intriguing hypothesis is that beneficial bacteria might serve as physical barriers that block pathogenic MAMPs (e.g., lipopolysaccharides) from activating host pattern-recognition receptors such as TLR2 and TLR4 by binding to them instead, thereby preventing pro-inflammatory responses [95] .
Prebiotics may act in a similar capacity, as there is evidence of direct interaction between oligosaccharides and the epithelium, independent of gut bacteria, with substantial reductions in pro-inflammatory cytokines [96, 97] . [98] , permitting access to potential pathogenic entities. Cytokines alter concentrations of several neurotransmitters that regulate communication in the brain, including serotonin, dopamine, and glutamate [99] . Cytokines can also enter the brain through active uptake, [ 2 2 2 _ T D $ D I F F ] stimulating secretion of pro-inflammatory substances such as prostaglandins [100] , precipitating further inflammation. There is also emerging evidence of a lymphatic drainage system subserving the brain [101] , which we speculate may allow The reader is referred to existing research in this area [103] [104] [105] .
A parasitic infection study [106] yielded an important mechanistic insight regarding cytokine roles in microbiome-brain signalling. Healthy male AKR mice were infected with the Trichuris muris parasite, following which they were treated with Bifidobacterium longum NCC3001, Lactobacillus rhamnosus NCC4007, or vehicle. Infection increased anxious behaviour and reduced hippocampal BDNF mRNA levels. Bifidobacterium longum NCC3001 (but not Lactobacillus rhamnosus NCC4007) reduced anxious behaviour and normalised BDNF mRNA concentrations. However, these changes occurred in the absence of prebiotic-induced reductions in any pro-inflammatory cytokines. This may be interpreted as evidence that psychobiotic effects also occur through mechanisms other than cytokine reduction.
Pro-inflammatory cytokines are also known to compromise the integrity of the gut barrier [107, 108] . 
Future Directions and Psychobiotics beyond Prebiotics and Probiotics
Narrative reviews of psychobiotics, including this one, are largely enthusiastic about the field. However, a recent systematic review of psychiatric benefits of probiotics in humans found little evidence of positive outcomes [121] , a finding running counter to the general optimism. [122] . Numerous limitations must both constrain enthusiasm and stimulate further investigations. For example, many studies examine several psychophysiological variables, of which only a few register effects. While exciting, issues of false-positives and false-negatives have not been adequately investigated. To a large extent, greater statistical power will add resolution. However, a range of conceptual and technical issues require exploration, which will both provide further mechanistic insights and pave the way for the emergence of systematic and efficient psychobiotics (Table 2) .
It is also worthwhile considering a wider definition of psychobiotics that need not be limited to probiotics and prebiotics. Indeed, any substance that exerts a microbiome-mediated psychological effect is potentially a psychobiotic, or at least possesses psychobiotic properties. For example, ingestion of the antipsychotic olanzapine has been shown to increase relative abundance of Actinobacteria and Proteobacteria, and is associated with weight gain [123] . However, a mixture of antibiotics (neomycin, metronidazole, and polymyxin) has also been shown to ameliorate the effects of the olanzapine on the relative abundance of bacterial families and [ 6 6 _ T D $ D I F F ] concomitant weight gain in rats [124] . Antibiotic mixtures (e.g., bacitracin, neomycin, and pimaricin) have been shown to induce neurochemical and behavioural changes through effects on the microbiome [73] , and chronic ingestion of antibiotics can permanently alter microbiome composition and metabolism [125] . Therefore, both antibiotics and antipsychotics may also be classified as psychobiotics. Antibiotic and antipsychotic effects on [123] [124] [125] illustrate the importance of considering the microbiome in side-effects assessments during clinical trials, which is currently not on the research agenda. Indeed, many substances may exert secondary psychobiotic effects through the microbiome alongside their primary intended effects. Some of these areas are being explored in the emerging field of pharmacomicrobiomics [126] . Beyond medical signals, the microbiome is sensitive to diet [83, 127, 128] and exercise [129] , both of which affect mood and cognition, and both of which affect vagal activity [61, 130, 131] , therefore sharing a signalling mechanism with other psychobiotics. It is possible the psychological effects of diet and exercise are partially mediated by the microbiome, and in this case, an argument may be made for them possessing psychobiotic properties. How do prebiotics and probiotics differ in terms of their impact on microbiome structure and relative abundance?
Are there undetected psychophysiological costs alongside the observed benefits of psychobiotics?
Does the brain adapt to long-term psychobiotic ingestion?
How do bacteria-derived blood metabolites affect the central nervous system, and how do psychobiotics modulate this relationship?
What is the time-course for emergence of various psychobiotic effects, and how long do they last?
Are there ceiling effects on psychobiotic benefits?
What are the functional implications of altered excitation-inhibition balance (due to alterations in GABA and glutamate concentrations) in [ 
